- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Urinary Bladder Diseases in New Zealand
Total 44336 results
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
National Cancer Institute (NCI)Not yet recruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | Recurrent Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; University... and other collaboratorsRecruitingBladder CancerUnited States, Japan
-
Southwest Oncology GroupNational Cancer Institute (NCI); University of Southern California; NCIC Clinical...TerminatedBladder CancerUnited States, Canada
-
National Cancer Institute (NCI)RecruitingStage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Metastatic Bladder Carcinoma | Advanced Bladder Carcinoma | Advanced Genitourinary System Carcinoma | Metastatic Genitourinary System CarcinomaUnited States
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Ureter Cancer | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Stage III Urethral Cancer | Stage IV Urethral CancerUnited States
-
Assembly BiosciencesNot yet recruitingRecurrent Genital Herpes Simplex Type 2New Zealand
-
Ethicon Endo-SurgeryNovella Clinical; Data & Inference, Inc.CompletedOveractive BladderUnited States
-
Northwell HealthWithdrawnInterstitial CystitisUnited States
-
Heinrich-Heine University, DuesseldorfTerminated
-
National Cancer Institute (NCI)RecruitingBladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Invasive Bladder Mixed CarcinomaUnited States, Guam, Puerto Rico
-
Dartmouth-Hitchcock Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at Birmingham and other collaboratorsRecruitingOveractive Bladder | Urinary Incontinence in Old Age | Urgency Urinary IncontinenceUnited States
-
UrigenCompletedPelvic Pain | Interstitial Cystitis | Bladder DiseasesUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedUrinary Bladder, OveractiveUnited States
-
University of California, San FranciscoPfizerCompletedOveractive Bladder | Urge Urinary IncontinenceUnited States
-
ViralyticsMerck Sharp & Dohme LLCCompletedBladder Cancer | Non-small Cell Lung CancerUnited States, United Kingdom, Australia
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Incyte CorporationRecruitingBladder Cancer | NMIBC | Urothelial Carcinoma Recurrent | Non-Muscle Invasive Bladder CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingBladder CarcinomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Urethral CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Poland
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Tyra Biosciences, IncRecruitingSolid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditionsAustralia, United States, France, Spain
-
AllerganRecruitingInterstitial Cystitis/Bladder Pain Syndrome (IC/BPS)United States, Canada
-
Ferring PharmaceuticalsRecruitingBladder CancerUnited States
-
UroGen Pharma Ltd.RecruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Urothelial Carcinoma Bladder | NMIBC | Urothelial Carcinoma Recurrent | Carcinoma in Situ of BladderUnited States, Italy, Spain
-
Icahn School of Medicine at Mount SinaiCelgeneTerminatedUrinary Bladder NeoplasmsUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
Matthew GalskyNovartis Pharmaceuticals; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma | Urothelial Carcinoma | Bladder CarcinomaUnited States
-
Englewood Hospital and Medical CenterTerminated
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
SanofiCompleted
-
National Institute of Diabetes and Digestive and...TerminatedInterstitial Cystitis | Painful Bladder SyndromeUnited States, Canada
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation...UnknownSpinal Cord Injuries | Urinary Bladder, NeurogenicUnited States
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerUnited States, Belgium, France, Germany, Italy, Spain, United Kingdom, Canada, Poland, Taiwan, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, Japan, Philippines, Israel, Chile, Australia, Netherlands, Russian Federation
-
zr Pharma & GmbHFoundation MedicineTerminatedBladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Muscle Invasive Bladder Cancer | Ureter Carcinoma | Renal Pelvis Carcinoma | Urinary Bladder Carcinoma | Urethra CarcinomaUnited States, Spain, France, Italy, Germany, United Kingdom
-
MedImmune LLCCompletedRenal InsufficiencyNew Zealand, Germany
-
MedtronicNeuroTerminatedOveractive Bladder | Fecal Incontinence | Non-obstructive Urinary RetentionUnited States, Netherlands, France, Canada, Switzerland, United Kingdom
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityUnited States, Belgium, Brazil, Denmark, Hungary, Korea, Republic of, Mexico, Philippines, Poland, Turkey
-
Matthew GalskyGenentech, Inc.CompletedUrothelial/Bladder Cancer, NosUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingStage III Bladder Cancer AJCC v8 | Bladder Urothelial CarcinomaUnited States
-
Tulane University Health Sciences CenterCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
Imbrium TherapeuticsPurdue Pharma LPRecruitingInterstitial Cystitis/Bladder Pain SyndromeUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; UConn Health; Adaptive Biotechnologies; MedGenomeCompleted
-
PfizerCompletedUrinary Bladder, OveractiveCanada, United States, Germany, Russian Federation, Czechia, Egypt, Bulgaria, Finland, Hungary, Korea, Republic of, Mexico, Poland, South Africa, Sweden, Ukraine
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom